Companies
4 companies · BioBio207940
Samsung Biologics
World's largest contract biologics manufacturer (CDMO). Produces biosimilars and biologics for global pharma.
₩66T
Mkt Cap
~12%
Foreign
▲ +1.43%
Bio128940
Hanmi Pharmaceutical
Korea's largest pharmaceutical company by revenue. Known for proprietary LAPSCOVERY long-acting platform technology, with multi-billion-dollar global licensing deals in obesity and diabetes therapeutics.
₩6T
Mkt Cap
~14%
Foreign
▲ +4.01%
Bio000100
Yuhan Corporation
Korean pharma with global Leclaza (lazertinib) royalty stream via Johnson & Johnson partnership for EGFR-mutated NSCLC.
₩8T
Mkt Cap
~19%
Foreign
▼ -0.42%
Bio068270
Celltrion
Korea's pioneering biosimilar company. Developed Remsima, the world's first antibody biosimilar. Expanding into novel biologics and global direct sales through Celltrion Healthcare integration.
₩46T
Mkt Cap
~24%
Foreign
▲ +0.98%
Last updated · May 22, 16:08 KST · KRX via Yahoo Finance